Replies to post #185407 on Biotech Values

[DewDiligence]

Thanks for that overview. I suspect MON knows as much about gene editing as any drug/biotech company. They’ve been doing it for quite a while.

p.s. MON’s FY1Q15 CC (1/7/15, 9:30am ET) includes the company’s annual pipeline update.

[DewDiligence]

MON’s annual pipeline update…

Press release:
http://finance.yahoo.com/news/agriculture-breakthroughs-poised-support-farmers-141500120.html

CC slides:
http://www.monsanto.com/investors/Documents/2016/2016.01.06_MON_Q1F16_Pipeline_Update.pdf

--
MON also reported FY1Q16 financial results today—please see #msg-119634026 for further info.